focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Statement by BERR

22 Sep 2008 11:15

RNS Number : 9543D
Phorm Inc
22 September 2008
 



22nd September 2008

Phorm, Inc. ("Phorm" or the "Company") 

Statement by Department for Business, Enterprise and Regulatory Reform 

The Department for Business, Enterprise and Regulatory Reform issued a statement (16.09.08) clarifying their response to a letter from the European Commission regarding Phorm's systems and technology. In Phorm's opinion, this statement clarifies the UK Government position on Phorm's technology. The full text of the statement was: 

"The UK is committed to providing a high level of consumer protection. We take our community obligations very seriously especially in the area of data protection and e-privacy. The possible future use of Phorm technology has raised material concerns in this area and the UK authorities are working to ensure that if it is introduced into the market for internet based advertising services, this is done in a lawful, appropriate and transparent fashion. 

After conducting its enquiries with Phorm the UK authorities consider that Phorm's products are capable of being operated in this fashion on the following basis:

the user profiling occurs with the knowledge and agreement of the customer 

the profile is based on a unique ID allocated at random which means that there is no need to know the identity of the individual users 

Phorm does not keep a record of the actual sites visited 

search terms used by the user and the advertising categories exclude certain sensitive terms and have been widely drawn so as not to reveal the identity of the user 

Phorm does not have nor want information which would enable it to link a user ID and profile to a living individual 

users will be presented with an unavoidable statement about the product and asked to exercise a choice about whether to be involved 

users will be able to easily access information on how to change their mind at any point and are free to opt in or out of the scheme. 

Future developments involving Phorm will be closely scrutinised and monitored by the enforcement authorities. "

For Phorm Enquiries:

Lynne Millar (Chief Financial Officer)

+44 20 7638 9571

Citigate Dewe Rogerson

+44 20 7638 9571

Simon Rigby

Justin Griffiths

Canaccord Adams Limited

+44 20 7050 6500

(Nominated Advisor)

Mark Williams

Andrew Chubb

About Phorm: 

Phorm is an innovative technology company specialising in delivering behaviorally and contextually targeted advertising while preserving users' personal privacy and security. 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm is a Delaware corporation, with offices in New YorkLondon and Moscow. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees.

For more information, please visit: www.phorm.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPUUQUBUPRGUP
Date   Source Headline
22nd Feb 20088:25 amRNSStockholder Meeting
14th Feb 20087:01 amRNSISP agreements
1st Feb 20088:55 amRNSExercise of Options
28th Jan 20087:01 amRNSTransfer of Shares
15th Jan 20087:00 amRNSManagement Appointment
11th Jan 20085:01 pmRNSExercise of Options
20th Dec 20075:47 pmRNSDirector/PDMR Shareholding
17th Dec 20071:56 pmRNSExercise of Options
30th Nov 20075:32 pmRNSHolding(s) in Company
7th Nov 20072:06 pmRNSExercise of Options
1st Oct 20077:02 amRNSDirectorate Change
28th Sep 20078:02 amRNSInterim Results
12th Sep 20079:33 amRNSHolding(s) in Company
20th Aug 20077:00 amRNSAIM Rule 26
27th Jul 20073:27 pmRNSDirector/PDMR Shareholding
17th Jul 200710:03 amRNSDirector Change - Replacement
17th Jul 20079:12 amRNSDirectorate Change
13th Jul 20071:26 pmRNSExercise of options
18th Jun 20074:50 pmRNSNotification of Interest
18th Jun 20077:01 amRNSAdditional Listing
15th Jun 20077:58 amRNSStmnt re Share Price Movement
6th Jun 20074:11 pmRNSHolding(s) in Company
21st May 20077:02 amRNSDirectorate Change
16th May 20074:17 pmRNSIssue of Equity
4th May 20077:00 amRNSRe-Organisation
3rd May 20077:01 amRNSRe-Organisation
2nd May 20072:01 pmRNSPress speculation
1st May 20078:20 amRNSSch 1 Update - Phorm, Inc.
27th Apr 20074:27 pmRNSSch 1 Update - Phorm, Inc.
26th Apr 200711:52 amRNSNotification of Holding
26th Apr 200711:24 amRNSResult of AGM
24th Apr 20077:02 amRNSAnnual Results
12th Apr 20073:45 pmRNSExercise of Options
2nd Apr 200711:02 amRNSSchedule 1 - Phorm, Inc
2nd Apr 20077:02 amRNSNotice of AGM
8th Mar 20077:04 amRNSDirectorate Change
27th Feb 20077:04 amRNSIssue of Equity
1st Feb 200712:40 pmRNSHolding(s) in Company
21st Dec 20063:33 pmPRNTotal Voting Rights
6th Dec 200612:21 pmPRNAdditional Listing
3rd Nov 20063:05 pmPRNStatement re Share Price Movement
18th Aug 200610:45 amPRNAdditional Listing
28th Jul 20067:00 amPRNAdditional Listing
25th Jul 200612:00 pmPRN121Media appoints David Dorman as Adviser
25th Jul 200610:45 amPRNShare Incentive Plan
21st Jul 20067:00 amPRNUpdate on Trading in and settlement of common shares
20th Jul 20067:00 amPRNDirector/PDMR Shareholding
19th Jul 20067:00 amPRNUpdate re: ISP Partnership Strategy
23rd Jun 20064:12 pmPRNFormal Notice
16th Jun 20067:00 amPRNAppointment of EVP Operations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.